Showing papers for search query "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"

     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Federal neglect: regulation of genetic testing
     Author ['GH Javitt', 'K Hudson']
     Venue Issues in Science and Technology
     Year 2006
     Abstract sight for genetic tests by, among other things, establishing a specialty area for genetic testing  the government announced in 2000 that it would establish a genet- ics specialty area, no  to perform high-complexity tests and must be labeled in accor- dance with FDA requirements
     Url https://www.jstor.org/stable/43314223


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Regulatory requirements for testing the donor blood supply
     Author ['SD Roseff']
     Venue Clinical Microbiology Newsletter
     Year 2005
     Abstract It serves as the "blood arm" of the FDA and is responsible for regulating biolog- ics that include blood and blood prod- ucts (www.fda.gov/cber)  In addition, if a facility is using a licensed NAT according to FDA requirements, HIV p24 antigen testing is not necessary (34)
     Url https://www.sciencedirect.com/science/article/pii/S0196439905800315


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Federal regulation of genetic testing neglect
     Author ['GH Javitt', 'K Hudson']
     Venue Issues in Science and Technology
     Year 2006
     Abstract sight for genetic tests by, among other things, establishing a specialty area for genetic testing  the government announced in 2000 that it would establish a genet- ics specialty area, no  to perform high-complexity tests and must be labeled in accor- dance with FDA requirements
     Url http://search.proquest.com/openview/3f1fb176f0d245c2b832290df7777590/1?pq-origsite=gscholar&cbl=32581


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Regulatory Requirements and Registration Procedure for Generic Drugs in USA
     Author ['N Rafi', 'S DS', 'A Narayanan']
     Venue Indian journal of pharmaceutical education …
     Year 2018
     Abstract regulatory authorities is to ensure that the drug development, manufacture and testing has been  patent ends or patent owner waives his rights and the FDA requirements are met  Pharmacology, pharmacokinet- ics, toxicology studies which are important to prove the safety and
     Url http://ijper.org/sites/default/files/IndJPhaEdRes_52_4_544_0.pdf


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Direct-to-Consumer Genetic Testing: The FDA's Dual Role as Safety and Health Information Regulator
     Author ['CM Sharkey']
     Venue DePaul L. Rev.
     Year 2018
     Abstract Page 1. DIRECT-TO-CONSUMER GENETIC TESTING: THE FDA'S DUAL ROLE AS SAFETY AND HEALTH INFORMATION REGULATOR Catherine M. Sharkey  345 I. A SHIFTING REGULATORY REGIME FOR DTC GENETIC TESTING: THE CASE OF 23ANDME
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/deplr68&section=20


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Computer validation and ethical security measures for pharmaceutical data processing
     Author ['OG Bhusnure', 'SP Kendre', 'DR Kaudewar']
     Venue World Journal of …
     Year 2015
     Abstract The computer systems in question included autoclave PLCs and SCADA systems  validation should demonstrate that all Part 11 requirements have been met. Computers and  The validation of a computerized control system to FDA requirements can be broken down
     Url https://www.researchgate.net/profile/Dr_Omprakash_Bhusnure/publication/289537776_COMPUTER_VALIDATION_AND_ETHICAL_SECURITY_MEASURES_FOR_PHARMACEUTICAL_DATA_PROCESSING/links/568fdb0908aec14fa5578fbf/COMPUTER-VALIDATION-AND-ETHICAL-SECURITY-MEASURES-FOR-PHARMACEUTICAL-DATA-PROCESSING.pdf


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act
     Author ['HG Grabowski', 'JM Vernon']
     Venue The journal of law and …
     Year 1992
     Abstract limited prior to 1984 because of costly Food and Drug Administration (FDA) requirements that had  was in the antibiotics category, where entry did not require duplicative safety and efficacy testing  than attempting to match the prices of the lower-priced gener- ics, the originators
     Url https://www.journals.uchicago.edu/doi/pdfplus/10.1086/467257


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Implications of FDA's Proposal to Include Foreign Marketing Experience in the Over-the-Counter Drug Review Process
     Author ['RG Pinco']
     Venue Food & Drug LJ
     Year 1998
     Abstract lists acceptable conditions: active ingredients, dosages, permissible combinations of ingre- dients, warnings and cautions, labeling requirements, and testing procedures for  As a result, many of the products that are considered cosmet- ics in Europe are categorized as drugs in
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/foodlj53&section=27


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Misplaced Fears in the Legislative Battle Over Affordable Biotech Drugs
     Author ['DE Adelman', 'CM Holman']
     Venue Idea
     Year 2009
     Abstract can not be used by producers of FOBs to satisfy FDA testing require- ments  of time, the high barrier to market entry associated with the stringent FDA requirements for clinical  www.ftc.gov/speeches/ harbour/070614genbio.pdf) (suggesting that "for many biolog- ics, patents may
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/idea50&section=28


     Search term "Cyber-physical+system"+OR+"Industrial+control+system"+OR+"ICS"+OR+"SCADA"+OR+"Distributed+control+system"+OR+"DCS"+"FDA+Requirements"+"Software+Validation"+OR+"Software+Verification"+OR+"Testing"
     Title Direct-to-Consumer Genetic Testing: The FDA's Dual Role as Safety and Health Information Regulator
     Author ['CM Sharkey']
     Venue DePaul Law Review
     Year 2019
     Abstract Article 11 Direct-to-Consumer Genetic Testing: The FDA's Dual Role as  Part of the Law Commons Recommended Citation Catherine M. Sharkey, Direct-to-Consumer Genetic Testing: The FDA's Dual Role as Safety and Health Information Regulator, 68 DePaul L. Rev
     Url https://via.library.depaul.edu/cgi/viewcontent.cgi?article=4086&context=law-review

